美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
63323-402-30	63323-402	HUMAN PRESCRIPTION DRUG	Aztreonam	AZTREONAM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091105	N/A	ANDA	ANDA065439	Fresenius Kabi USA, LLC	AZTREONAM	2 g/1	10 VIAL in 1 TRAY (63323-402-30) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63323-402-03)
63323-401-20	63323-401	HUMAN PRESCRIPTION DRUG	Aztreonam	AZTREONAM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091105	N/A	ANDA	ANDA065439	Fresenius Kabi USA, LLC	AZTREONAM	1 g/1	10 VIAL in 1 TRAY (63323-401-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63323-401-01)
63323-401-26	63323-401	HUMAN PRESCRIPTION DRUG	Aztreonam	AZTREONAM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091105	N/A	ANDA	ANDA065439	Fresenius Kabi USA, LLC	AZTREONAM	1 g/1	10 VIAL in 1 TRAY (63323-401-26) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63323-401-21)
63323-402-24	63323-402	HUMAN PRESCRIPTION DRUG	Aztreonam	AZTREONAM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091105	N/A	ANDA	ANDA065439	Fresenius Kabi USA, LLC	AZTREONAM	2 g/1	10 VIAL in 1 TRAY (63323-402-24) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63323-402-41)
63323-401-24	63323-401	HUMAN PRESCRIPTION DRUG	Aztreonam	AZTREONAM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091105	N/A	ANDA	ANDA065439	Fresenius Kabi USA, LLC	AZTREONAM	1 g/1	10 VIAL in 1 TRAY (63323-401-24) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63323-401-41)
63323-402-20	63323-402	HUMAN PRESCRIPTION DRUG	Aztreonam	AZTREONAM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091105	N/A	ANDA	ANDA065439	Fresenius Kabi USA, LLC	AZTREONAM	2 g/1	10 VIAL in 1 TRAY (63323-402-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63323-402-01)